— Know what they know.
Not Investment Advice
Also trades as: 0A23.L (LSE) · $vol 0M

PHR NYSE

Phreesia, Inc.
1W: +11.9% 1M: +24.3% 3M: +16.2% YTD: -22.6% 1Y: -46.3% 3Y: -19.9% 5Y: -80.1%
$12.29
-0.32 (-2.54%)
After Hours: $11.32 (-0.97, -7.89%)
Weekly Expected Move ±5.2%
$11 $12 $13 $13 $14
NYSE · Healthcare · Medical - Healthcare Information Services · Tech Score Strong Buy · Power 72 · $782.7M mcap · 49M float · 1.65% daily turnover · Short 51% of daily vol
Credit Risk of going bust: lower than 50% of companies Debt: 8.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.14 (down 99%), Phreesia, Inc. would be worth roughly what it owes.
Total debt $67.9M against a stock market value of $782.7M.
Distance to default 5.13 (Merton model): prices to 2026-10-26, balance sheet 2026-07-31, debt counted $34.4M (short-term plus half of long-term), stock volatility 61.7%; Altman Z'' -1.27. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Smart Money Score
Moderate 50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$782.7M
52W Range7.77-23.87
Volume574,947
Avg Volume810,405
Beta0.84
Dividend—
Analyst Ratings
18 Buy 8 Hold 0 Sell
Consensus Buy
Company Info
CEOChaim Indig
Employees1,789
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2019-07-18
1521 Concord Pike
Wilmington, DE 19803
US
888 654 7473
About Phreesia, Inc.

Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.

Recent Insider Trades

NameTypeSharesPriceDate
Linetsky David P-Purchase 35 $9.15 2026-10-22
Linetsky David P-Purchase 35 $10.35 2026-10-22
Hoffman Allison C S-Sale 6,662 $10.08 2026-09-21
VanDuyn Amy Beth F-InKind 2,876 $10.42 2026-09-18
Roberts Evan F-InKind 4,476 $10.42 2026-09-18

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms